Voyager Therapeutics, Inc. 10-Q

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Inducement Grant Awards ​ On September 19, 2022, we issued to two executives non-statutory stock options to purchase an aggregate of 276,000 shares of our common stock at an exercise price of $4.40 per share. The options were granted outside of our 2015 Stock Option Plan, in each case, as an inducement material to such executive’s acceptance of an offer of employment with us in accordance with Nasdaq Listing Rule 5635(c)(4). We intend to file a registration statement on a Form S-8 to register the shares of common stock underlying the stock options prior to the time at which the shares underlying the options become exercisable. ​ Repurchases of Common Stock ​ The following table sets forth information with respect to repurchases of shares of our common stock during the three months ended September 30, 2022. ​ ​ ​ ​ ​ ​ Period Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs July 1 – July 31, 2022 72,647 (1) $0.0425 - - August 1 – August 31, 2022 - - - - September 1 – September 30, 2022 - - - - Total 72,647 $0.0425 - - ​ (1) During the three months ended September 30, 2022, we modified one of our founder’s performance awards, repurchasing 72,647 shares of common stock previously issued thereunder. ​